There isn’t any….Is this what you want?
How many studies do you want Prof G to be doing at once?
You can only spread yourself so much……………..
Who is helping getting CAMPATH through the Regulatory Process….? Its not your “Noble Prize Elect”…..who’s on leave for the Year.
Doing trials are one thing, Coming up with the Idea in the first place is another and getting drugs to the Mser is yet another problem
DMTs; some recently approved in USA, and more on their way in Europe. In UK the price will be the major hurdle.
When will drugs be available?…Ask the regulators and companies…we have no control on their pricing..which along with side effects and efficacy and your postcode will determine availability.
Neuroprotectants….get on a trial if you can now!
Closest to Market will be Fingolimod, that is if it works for Progression. The PPMS trial is fully recruited.
Maybe BG-12 is neuroprotective, but will get licence for RRMS in the UK?
International progressive multiple sclerosis collaborative moved forward yesterday……more potential treatments coming your way.
…We need to help the organisers realise their vision on this one.
Repair is years away. Anti-Lingo has finished phase I, so you have phase II and Phase III to complete.
RXR compounds assuming they are safe and that some pharma is behind this, still years away I am afraid.